secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001193125-24-154380
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics draws $3.3M from Pershing facility to repay Oxford term loan in full
--------------------------------------------------------------------------------

- Drew $3.3M from Pershing margin loan facility at FOMC target (floor 5.5%) + 1.75% spread + 0.5% fees, max Prime+3%.
- On June 3, 2024, used the draw to repay and terminate the Oxford Finance term loan, totaling approx. $3.3M.
- Repayment eliminated Oxford's security interest in all of Plus Therapeutics' assets and related covenants.
- Pershing credit line is secured by collateralized marketable securities; can draw up to 91.5% of collateral value.
- Outstanding balance is due on demand; Pershing may require additional collateral or liquidate securities upon default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/0001193125-24-154380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/d840235d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer